Assessment of five serum marker assays in patients with advanced breast cancer treated with medroxyprogesterone acetate
- 1 September 1995
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 31 (10) , 1605-1610
- https://doi.org/10.1016/0959-8049(95)00332-d
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Explanatory and pragmatic attitudes in therapeutical trialsPublished by Elsevier ,2004
- Simple cytokeratins in the serum of patients with lung cancer: Relationship to cell deathEuropean Journal Of Cancer, 1994
- Erlangen tumor marker study on breast cancerEuropean Journal Of Cancer, 1993
- Fine specificity of antibody recognition of carcinoma-associated epithelial mucins: Antibody binding to synthetic peptide epitopesEuropean Journal Of Cancer, 1993
- Immunodiagnosis of TumoursEuropean Journal Of Cancer, 1993
- The use of serum tumor markers in the management of patients with malignancyZeitschrift für Krebsforschung und Klinische Onkologie, 1993
- A core protein epitope of the polymorphic epithelial mucin detected by the monoclonal antibody SM‐3 is selectively exposed in a range of primary carcinomasInternational Journal of Cancer, 1989
- High molecular weight epithelial mucins as markers in breast cancerEuropean Journal of Cancer and Clinical Oncology, 1988
- Heterotypic tetramer (A2D2) complexes of non-epidermal keratins isolated from cytoskeletons of rat hepatocytes and hepatoma cellsJournal of Molecular Biology, 1984
- The catalog of human cytokeratins: Patterns of expression in normal epithelia, tumors and cultured cellsPublished by Elsevier ,1982